Soleo Health helps to ramp up home infusion advocacy

 - 
Wednesday, May 24, 2017

MCKINNEY, Texas – Soleo Health, a national provider of specialty home and alternate-site infusion services, has joined Keep My Infusion Care at Home, an industry backed coalition that advocates for Medicare patients who are losing access to their treatment. Soleo Health has also authored a white paper that provides details on the impact of the 21st Century Cures Act on these patients. A provision in the act modifies the payment structure for certain infusion drugs under the Part B benefit, drastically reducing their reimbursement. The modification, which went into effect Jan. 1, essentially means that payments now cover only drug costs, not clinical services. “Home infusion has become a life-saving, cost-effective solution for more than 10 million Americans today,” said Drew Walk, CEO at Soleo Health. “Keeping care at home has sustained patients’ quality of life and better managed the costs associated with their respective conditions. With the new 21st Century Cures Act, these patients stand to be significantly compromised. Action must be taken immediately to help them remain at home, as this will benefit not only their health and wellbeing but our overall healthcare system, as well.” Another provision in the act provides payments for clinical services, but not until 2021, creating a four-year payment gap.